Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation
- PMID: 22795433
- DOI: 10.1016/j.amjopharm.2012.06.003
Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation
Abstract
Background: Medications with anticholinergic (antimuscarinic) effects negatively affect physical and cognitive function in community-dwelling older patients. However, it is unknown if anticholinergic drugs exert detrimental effects in older patients undergoing rehabilitation.
Objective: The purpose of our study was to assess the effect of anticholinergic drug exposure on functional outcomes in older patients undergoing rehabilitation. We speculated that higher anticholinergic drug exposure would be associated with reduced functional outcomes in this group.
Methods: Data on clinical characteristics, full medication, anticholinergic drug exposure (total number of anticholinergic drugs [tAD] and Anticholinergic Risk Scale [ARS] score), and Barthel index (BI) score were collected on admission and discharge in a consecutive series of 117 older patients (age 79 [7] years) admitted to the orthopaedic rehabilitation unit of a teaching hospital between July 2010 and March 2011. Outcome measures were BI changes (BI on discharge - BI on admission) during rehabilitation (primary outcome) and length of stay (secondary outcome).
Results: Anticholinergic drugs were prescribed in 38 patients (32.5%). Median and interquartile range for tAD = 0 (0-1); for ARS = 0 (0-1). Poisson regression showed that higher tAD (incidence rate ratio [IRR] = 0.92; 95% CI, 0.88-0.97; P = 0.003) and ARS scores (IRR = 0.97; 95% CI, 0.95-0.99; P = 0.008) on admission independently predicted lower BI changes. Being a woman (IRR = 0.87; 95% CI, 0.78-0.97; P = 0.01), lower Abbreviated Mental Test scores (IRR = 0.94; 95% CI, 0.91-0.97; P < 0.001), and lower BI on admission (IRR = 0.98; 95% CI, 0.97-0.98; P < 0.001), but not tAD or ARS scores, independently predicted increasing length of stay.
Conclusions: Higher anticholinergic drug exposure on admission independently predicts reduced functional outcomes, but not length of stay, in older patients undergoing orthopaedic rehabilitation.
Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved.
Similar articles
-
Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients.Hosp Pract (1995). 2011 Feb;39(1):30-6. doi: 10.3810/hp.2011.02.371. Hosp Pract (1995). 2011. PMID: 21441756
-
Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures.Am J Geriatr Psychiatry. 2013 Aug;21(8):785-93. doi: 10.1016/j.jagp.2013.01.012. Epub 2013 Feb 6. Am J Geriatr Psychiatry. 2013. PMID: 23567395
-
The anticholinergic risk scale and anticholinergic adverse effects in older persons.Arch Intern Med. 2008 Mar 10;168(5):508-13. doi: 10.1001/archinternmed.2007.106. Arch Intern Med. 2008. PMID: 18332297
-
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.Br J Clin Pharmacol. 2015 Aug;80(2):209-20. doi: 10.1111/bcp.12617. Epub 2015 May 20. Br J Clin Pharmacol. 2015. PMID: 25735839 Free PMC article.
-
Drugs with anticholinergic properties: a current perspective on use and safety.Expert Opin Drug Saf. 2011 Sep;10(5):751-65. doi: 10.1517/14740338.2011.579899. Epub 2011 Jun 2. Expert Opin Drug Saf. 2011. PMID: 21635190 Review.
Cited by
-
Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia.Am J Geriatr Psychiatry. 2015 Dec;23(12):1250-1258. doi: 10.1016/j.jagp.2015.07.004. Epub 2015 Jul 31. Am J Geriatr Psychiatry. 2015. PMID: 26419732 Free PMC article. Clinical Trial.
-
Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients.Pharmacol Res Perspect. 2017 May 11;5(3):e00310. doi: 10.1002/prp2.310. eCollection 2017 Jun. Pharmacol Res Perspect. 2017. PMID: 28603629 Free PMC article.
-
Central Anticholinergic Adverse Effects and Their Measurement.Drugs Aging. 2015 Dec;32(12):963-74. doi: 10.1007/s40266-015-0321-6. Drugs Aging. 2015. PMID: 26518014
-
The Association between Anticholinergic Drug Use and Rehabilitation Outcome in Post-Acute Hip Fractured Patients: A Retrospective Cohort Study.Drugs Aging. 2018 Apr;35(4):333-341. doi: 10.1007/s40266-018-0533-7. Drugs Aging. 2018. PMID: 29500684
-
Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures.Br J Clin Pharmacol. 2015 Nov;80(5):1169-75. doi: 10.1111/bcp.12670. Epub 2015 Jul 6. Br J Clin Pharmacol. 2015. PMID: 25923961 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources